New Green Hemp Inc. (OTCPK: NGHI)
Health Care · Pharmaceuticals · US
$1.28
-16.34% today · +151.0% 1Y
New Green Hemp Inc. (OTCPK: NGHI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $32.30M and employs 5 people.
Over the last twelve months the share price has gained 151.0%, trading between 0.20 and 3.89.
Tweenvest scores New Green Hemp Inc. across four factors: quality 61/100, value 50/100. Its strongest factor is quality.
NGHI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $32.30M
- Revenue (TTM)
- $121.00K
- P/E
- 3.25
- EPS
- 0.39
- Dividend yield
- —
- Beta (5Y)
- 2.36
- 52-week high
- $3.89
- 52-week low
- $0.20
- Avg volume (3M)
- —
- Shares outstanding
- 25.24M
- Employees
- 5
- Next earnings
- —
About New Green Hemp Inc.
New Green Hemp Inc., established in 2013 and headquartered in Tallahassee, Florida, specializes in the cultivation and sale of various hemp products. The company adopted its current name in December 2024, having previously operated under the name Galenfeha, Inc.
- ISIN
- US3633772013
- Founded
- 2013
- Listed since
- Sep 26, 2014
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.